Introduction
Evidence has accumulated that implicates prostaglandin (PG) F-2a as the uterine luteolysin in the pig. Increased plasma PGF in the utero-ovarian vein on Days 14-16 of the oestrous cycle (Gleeson, Thorburn & Cox, 1974; Killian, Davis & Day, 1976; Moeljono et al, 1977) corresponds to the stage of the cycle when the presence or absence of the uterus determines the regression or maintenance of the corpus luteum (Anderson, Butcher & Melampy, 1963) . Injections of PGF-2a (Gleeson, 1974;  Hallford, Wettemann, Turman & Omtvedt, 1975) or its 16-aryloxy analogues (Guthrie & Polge, 1976 caused luteolysis when corpora lutea were about 10 days old (Day 12 of the oestrous cycle or pregnancy). Patek & Watson (1976a) have proposed that luteal PGF-2a synthesis in vivo might be involved in the process of luteolysis. They reported that luteal and endometrial PGF release in vitro was highest in tissues collected during the late luteal phase of the cycle. However, Guthrie, Rexroad & Bolt (1978) (Guthrie, 1977; . The antiserum (465/5 provided by Dr . J. A. Furr, I.C.I., Macclesfield, England) was produced in a goat to an lla-progesterone-succinyl-bovine serum albumin conjugate. The antiserum was used at a dilution of 1:5000 and 100 ul bound 60% of 0-01 \yC'\ [l,2,6,7-3H] progesterone in an incubation volume of 0-3 ml per assay tube. Only 17a-hydroxyprogesterone, pregnenolone and 17a-hydroxypregnenolone had cross-reactivity of >0-5% (1, 3-4 and 1-3%, respectively). The progesterone standards were dissolved in distilled water and extracted along with the samples.
The sensitivity of the assay was 15-20 pg/tube at 90-95% binding, and the intra-assay and inter-assay coefficients of variability were 8-2 and 9-0%, respectively.
Prostaglandin F was measured in aliquots of undiluted medium from the luteal and endometrial tissue incubations without extraction (Rexroad, 1978) . The procedure was a double antibody radioimmunoassay with goat anti-PGF-2a as the first antibody (10142-JCC-50, a gift of Dr . T. Kirton, Upjohn Co., Kalamazoo) and rabbit anti-goat globulin (DJB 3x1, provided by Dr D. J. Bolt, this laboratory) as the second antibody. The antibody cross-reacted about 16% with PGF-la and <0-016% with PG A-l, A-2, B-2, E-l and E-2. Recovery of 0-2-1-6 ng PGF-2a added to laboratory standards (see below) and assayed directly was 110 ± 5% (n = 14, r = 0-99), and recovery from a pool of medium samples from pig luteal tissue incubations was 119 ± 14% (n = 15, r = 0-92). The laboratory standards were supernatants of ovine uterine myometrium homogenates that had low (indomethacin-treated) or high (cycloheximide-treated) concentrations of PGF in relation to the standard curve. The laboratory standards were included in all assays and had intra-and inter-assay coefficients of variability of 8-6 and 14-1%, respectively.
The hormone concentration of the incubation medium was analysed as a split-plot design; least squares analysis of variance was used. The whole-unit analysis consisted of the 5 (Poyser, 1972) and ewes (Patek & Watson, 1976b; Roberts, McCracken, Gavagan & Soloff, 1976) ; the increased release of PGF coincided with the time of luteolysis. In an earlier experiment , we found that endometrial synthesis of PGF in vitro was greater on Days 15-16 of the cycle than on Days 7-8 although the difference was not statistically significant. Plasma progesterone averaged 11-2 ng/ml on Days 15-16, indicating that luteolysis had not proceeded to the degree found in the present experiment. In our present experiment, the highest level of endometrial PGF release coincided with very low plasma progesterone and progesterone release in vitro. In the pig (Gleeson et al, 191A; Killian et al, 1976; Moeljono et al, 1977) and ewe (Cox, Thorburn, Currie, Restall & Schneider, 1972) (Scaramuzzi, Baird, Boyle, Land & Wheeler, 1977) .
The pattern of progesterone release in vitro appears to differ from that of the secretion of progesterone in vivo into peripheral plasma (Text- fig. 1 
